Betamethasone dipropionate
From Wikipedia, the free encyclopedia
 |
|
|
Betamethasone dipropionate
|
|
| Systematic (IUPAC) name | |
| 9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12, 13,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | A07 C05AA05, D07AC01, D07XC01, H02AB01, R01AD06, R03BA04, S01BA06, S01CB04, S02BA07, S03BA03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C28H37FO7 |
| Mol. mass | 504.6 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 64% |
| Metabolism | hepatic |
| Half life | 5.6 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | topical |
Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive abilities. It is applied as a topical cream, ointment, lotion or gel (Diprolene®) to treat itching (e.g. from eczema).
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
